| Schedule of Statutory Accounting Practices Disclosure |
The following represents the effect of the permitted practices to the statutory financial statements: | | | | | | | | | | | | | | | | | | | | | | | | | December 31, 2025 | | (In millions) | ALRe | | AARe | | ACRA 1A | | ACRA 2A | | Increase (decrease) to capital and surplus due to permitted practices | $ | 1,982 | | | $ | 808 | | | $ | 2,655 | | | $ | 54 | | | Increase (decrease) to statutory net income due to permitted practices | (663) | | | (644) | | | (1,752) | | | 62 | |
The following represents the maximum distribution Athene’s Bermuda subsidiaries would be permitted to remit to its parent without the need for prior approval: | | | | | | | | | | | | | | | (In millions) | December 31, 2025 | | December 31, 2024 | | ALRe | $ | 9,842 | | | $ | 10,112 | | | AARe | 12,888 | | | 10,207 | | | ACRA 1A | 614 | | | 1,044 | | | ACRA 2A | 2,174 | | | 877 | |
Athene’s primary regulated U.S. subsidiaries and the corresponding insurance regulatory authorities are as follows:
| | | | | | | | | | Subsidiary | | Regulatory Authority | | AAIA | | Iowa Insurance Division | | AANY | | New York Department of Financial Services | | Athene Re USA IV | | State of Vermont Department of Financial Regulation |
The following table presents, for each of Athene’s primary insurance subsidiaries, the best estimates of statutory capital and surplus and the statutory net income (loss) as of the date these financial statements were issued:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Statutory capital & surplus | | Statutory net income (loss) | | December 31, | | Years ended December 31, | | (In millions) | 2025 | | 2024 | | 2025 | | 2024 | | 2023 | | ALRe | $ | 13,702 | | | $ | 17,623 | | | $ | 612 | | | $ | 3,140 | | | $ | 832 | | | AARe | 23,713 | | | 21,049 | | | 2,774 | | | 2,910 | | | 408 | | | ACRA 1A | 3,822 | | | 4,521 | | | (247) | | | 841 | | | 297 | | | ACRA 2A | 6,585 | | | 4,569 | | | 1,090 | | | 877 | | | (759) | | | AAIA | 4,122 | | | 3,899 | | | 1,092 | | | 949 | | | (79) | | | AANY | 394 | | | 318 | | | 25 | | | 25 | | | (3) | |
|